Please assess the completion status of the following clinical trial:

Trial Title: Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. On Dilantin for seizure prophylaxis (dose determined by primary caregiver) with therapeutic Dilantin levels~2. Receiving enteral nutrition by the interrupted method at goal feeding rate~3. Age \>18~4. Feeding tube in proper position, no restriction as to type of feeding tube (nasogastric, nasoduodenal, gastrostomy, jejunostomy), but both Dilantin and enteral feeding must be given through the same tube~Exclusion Criteria:~1. History of seizures~2. Albumin infusions necessary during study period~3. Anticipation that feedings will need to be held for more than 4 hours at a time~4. Patients that do not maintain stable Dilantin levels (\< 25% variability) with the interrupted method of feeding~5. Inability to obtain consent from patient or spokesperson

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).